Chao Xingjuan sold $841K of CBLL
Chao Xingjuan (President and CEO) sold 33,614 shares of Ceribell, Inc. (CBLL) at an average of $25.03 ($25.00–$25.03, $0.84M total) across 2 trades over 2026-08-18 to 2026-08-19 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Provides fresh data on insider holdings; modest sell‑off may be interpreted by short‑term traders.
Market read
New insider sale information for CBLL, modest in size, limited trading relevance.
What to watch
Potential upcoming financing or strategic moves not disclosed.
Background
Form 4 filing discloses insider transactions required by SEC regulations.
Ticker impact
President and CEO Chao Xingjuan sold 33,614 shares for $841,292.45 via a 10b5-1 plan, reducing his stake to 787,799 shares.
Potential slight downward pressure, likely limited to a few basis points.
Sale amount is under $1M and follows a pre‑arranged plan, reducing actionable significance.
Market effects
Minimal impact on the medical‑device sector; insider activity is routine.
No regional effect beyond Ceribell shareholders.
Limited to investors tracking insider transactions.
Counterpoint
The sale could be unrelated to company outlook, merely portfolio rebalancing.
Key entities
- CompanyCeribell, Inc.
Medical‑device firm developing seizure detection technology.
- ExecutiveChao Xingjuan
President and CEO of Ceribell.